HELEN HESLOP to Carcinoma
This is a "connection" page, showing publications HELEN HESLOP has written about Carcinoma.
Connection Strength
0.236
-
Combining drugs and biologics to treat nasopharyngeal cancer. Mol Ther. 2014 Jan; 22(1):8-9.
Score: 0.086
-
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother. 2010 Nov-Dec; 33(9):983-90.
Score: 0.069
-
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients. Blood. 2009 Mar 12; 113(11):2442-50.
Score: 0.060
-
Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. J Immunother. 2014 May; 37(4):193-203.
Score: 0.022